GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.

Have any questions? Please email us at ecoliwiki@gmail.com

TableEdit

Jump to: navigation, search

PMID:19855400

You don't have sufficient rights on this wiki to edit tables. Perhaps you need to log in. Changes you make in the Table editor will not be saved back to the wiki

See Help for Help on this wiki. See the documentation for how to use the table editor

Citation

Li, X, Zhang, X, Leathers, R, Makino, A, Huang, C, Parsa, P, Macias, J, Yuan, JX, Jamieson, SW and Thistlethwaite, PA (2009) Notch3 signaling promotes the development of pulmonary arterial hypertension. Nat. Med. 15:1289-97

Abstract

Notch receptor signaling is implicated in controlling smooth muscle cell proliferation and in maintaining smooth muscle cells in an undifferentiated state. Pulmonary arterial hypertension is characterized by excessive vascular resistance, smooth muscle cell proliferation in small pulmonary arteries, leading to elevation of pulmonary vascular resistance, right ventricular failure and death. Here we show that human pulmonary hypertension is characterized by overexpression of NOTCH3 in small pulmonary artery smooth muscle cells and that the severity of disease in humans and rodents correlates with the amount of NOTCH3 protein in the lung. We further show that mice with homozygous deletion of Notch3 do not develop pulmonary hypertension in response to hypoxic stimulation and that pulmonary hypertension can be successfully treated in mice by administration of N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester (DAPT), a gamma-secretase inhibitor that blocks activation of Notch3 in smooth muscle cells. We show a mechanistic link from NOTCH3 receptor signaling through the Hairy and enhancer of Split-5 (HES-5) protein to smooth muscle cell proliferation and a shift to an undifferentiated smooth muscle cell phenotype. These results suggest that the NOTCH3-HES-5 signaling pathway is crucial for the development of pulmonary arterial hypertension and provide a target pathway for therapeutic intervention.

Links

PubMed PMC2780347 Online version:10.1038/nm.2021

Keywords

Animals; Anoxia/drug therapy; Anoxia/physiopathology; Basic Helix-Loop-Helix Transcription Factors/metabolism; Cell Proliferation/drug effects; Dipeptides/pharmacology; Dipeptides/therapeutic use; Disease Models, Animal; Enzyme Inhibitors/pharmacology; Enzyme Inhibitors/therapeutic use; Gene Expression Regulation/drug effects; Gene Expression Regulation/physiology; Humans; Hypertension, Pulmonary/drug therapy; Hypertension, Pulmonary/metabolism; Hypertension, Pulmonary/pathology; Lung/metabolism; Lung/pathology; Mice; Mice, Knockout; Microscopy, Electron, Transmission/methods; Myocytes, Smooth Muscle; Pulmonary Artery/metabolism; Pulmonary Artery/pathology; Pulmonary Artery/physiopathology; Pulmonary Artery/ultrastructure; RNA, Messenger/metabolism; Rats; Receptors, Notch/deficiency; Receptors, Notch/metabolism; Repressor Proteins/metabolism; Signal Transduction/drug effects; Signal Transduction/genetics; Signal Transduction/physiology; Time Factors

public



Cancel